Product Information
TEMOZOLOMIDE 20 MG CAPSULE is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $4.1124 per EA under NDC 75834014214. Its NADAC has been published 47 times since Apr 17, 2024.
Strength
20 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834014214
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213328On Market Since
12/7/2021
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 20 MG CAPSULE has been published 47 times since Apr 17, 2024, and over the history we have for it it has declined 14.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1124 per EA |
|---|---|
| All-time high | $4.8083 (Feb 12, 2025) |
| All-time low | $4.1124 (Feb 19, 2025) |
| Median price | $4.8083 |
| Average price | $4.7639 |
| Largest weekly change | -14.5% (Feb 19, 2025) |
| Weeks tracked | 47 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 72% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 20 MG CAPSULE, manufactured by Nivagen Pharmaceuticals Inc., is $4.1124 per EA (NDC 75834014214), effective Mar 5, 2025.
How has the price of TEMOZOLOMIDE 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 20 MG CAPSULE has declined 14.5%. It has been tracked across 47 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 20 MG CAPSULE?
Since Apr 17, 2024, the NADAC for TEMOZOLOMIDE 20 MG CAPSULE has ranged from a low of $4.1124 (Feb 19, 2025) to a high of $4.8083 (Feb 12, 2025), with a median of $4.8083 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 20 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TEMOZOLOMIDE 20 MG CAPSULE, is $1.1527 per EA — about 72% below TEMOZOLOMIDE 20 MG CAPSULE.
Who manufactures TEMOZOLOMIDE 20 MG CAPSULE?
TEMOZOLOMIDE 20 MG CAPSULE (NDC 75834014214) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification